These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6146156)

  • 1. The persistence of stimulant effects in chronically treated children: further evidence of an inverse relationship between drug effects and placebo levels of response.
    Gualtieri CT; Hicks RE; Mayo JP; Schroeder SR
    Psychopharmacology (Berl); 1984; 83(1):44-7. PubMed ID: 6146156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
    Ramtvedt BE; Røinås E; Aabech HS; Sundet KS
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):597-604. PubMed ID: 23659360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
    Elia J; Borcherding BG; Rapoport JL; Keysor CS
    Psychiatry Res; 1991 Feb; 36(2):141-55. PubMed ID: 2017529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
    Nolan EE; Gadow KD; Sprafkin J
    Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classroom academic performance: improvement with both methylphenidate and dextroamphetamine in ADHD boys.
    Elia J; Welsh PA; Gullotta CS; Rapoport JL
    J Child Psychol Psychiatry; 1993 Jul; 34(5):785-804. PubMed ID: 8340445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate versus dextroamphetamine in ADHD.
    Efron D
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):500. PubMed ID: 10230180
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulant drugs for severe hyperactivity in childhood.
    Drug Ther Bull; 2001 Jul; 39(7):52-4. PubMed ID: 11471516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial.
    Ramtvedt BE; Sundet K
    Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD.
    Sandler A; Glesne C; Geller G
    Child Care Health Dev; 2008 Jan; 34(1):111-20. PubMed ID: 18171452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose.
    Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder.
    Sprafkin J; Gadow KD
    J Child Adolesc Psychopharmacol; 1996; 6(4):215-28. PubMed ID: 9231315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D; Jarman F; Barker M
    Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
    Swanson JM; Wigal SB; Wigal T; Sonuga-Barke E; Greenhill LL; Biederman J; Kollins S; Nguyen AS; DeCory HH; Hirshe Dirksen SJ; Hatch SJ;
    Pediatrics; 2004 Mar; 113(3 Pt 1):e206-16. PubMed ID: 14993578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
    Arnold LE; Christopher J; Huestis R; Smeltzer DJ
    Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; McNairn N; Clavarino A
    Eur J Clin Pharmacol; 2007 Nov; 63(11):985-9. PubMed ID: 17701403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.